• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220

Research Brief on Trimethylamine-d9 Hydrochloride (CAS: 18856-86-5): Recent Advances and Applications

Trimethylamine-d9 Hydrochloride (CAS: 18856-86-5) is a deuterated analog of trimethylamine hydrochloride, widely used as a stable isotope-labeled internal standard in mass spectrometry-based metabolomics and pharmacokinetic studies. Recent research has highlighted its critical role in tracing metabolic pathways, particularly those involving trimethylamine N-oxide (TMAO), a metabolite linked to cardiovascular diseases and other metabolic disorders. This brief synthesizes the latest findings on its synthesis, applications, and emerging therapeutic implications.

A 2023 study published in Analytical Chemistry demonstrated the superior performance of Trimethylamine-d9 Hydrochloride in quantifying TMAO levels in human plasma with high precision (CV < 5%). The deuterated compound's stability under LC-MS conditions minimized matrix effects, enabling robust biomarker validation for atherosclerosis risk assessment. Researchers emphasized its utility in large-scale cohort studies, where isotopic purity (>98%) ensured data reproducibility.

Innovative synthetic routes for 18856-86-5 were reported in Journal of Labelled Compounds and Radiopharmaceuticals, featuring a novel catalytic deuteration method that achieved 99.5% isotopic enrichment at reduced production costs. This advancement addresses supply chain challenges for high-purity deuterated reagents, particularly for pharmaceutical companies developing TMAO-lowering therapies.

Emerging applications include its use as a tracer in gut microbiome studies, where isotopic labeling enabled precise mapping of dietary choline-to-TMAO conversion kinetics. A 2024 Nature Metabolism paper utilized Trimethylamine-d9 Hydrochloride to identify specific bacterial taxa responsible for pathogenic TMAO production, paving the way for targeted probiotic interventions.

Regulatory agencies have recently included 18856-86-5 in certified reference material lists for clinical diagnostics, reflecting its growing standardization in metabolic disease research. Current limitations include the need for improved storage protocols to prevent isotopic exchange in aqueous solutions, an area of active investigation by major reagent manufacturers.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)